Core Viewpoint - The company, Novogene, is focusing its research and development expenses on emerging businesses such as single-cell, spatial omics, proteomics, metabolomics, epigenetics, and long-read sequencing technologies, as part of its planned R&D activities [1] Summary by Categories - **Research and Development Focus** - The company is allocating its R&D expenses primarily towards new and emerging fields [1] - Specific areas of investment include single-cell analysis, spatial omics, proteomics, metabolomics, epigenetics, and long-read sequencing technologies [1]